Skip to main content
Premium Trial:

Request an Annual Quote

ViaLogy Expands Patent Portfolio into Biomarker Identification

NEW YORK, Jan. 6 (GenomeWeb News) - Active signal processing software firm ViaLogy said today that it has been issued a patent that extends its Quantum Resonance Interferometry (QRI) technology into the area of biomarker identification.

The patent, US No. 6,671,625, "Method and system for signal detection in arrayed instrumentation based on quantum resonance interferometry," covers the use of QRI in protein arrays, and "broadens applications of QRI to proteomics, pathway optimization, high-throughput screening, cellular assays and time-based dosing studies by gene expression," according to the company.

ViaLogy has already been issued three US patents -- numbers 6,245,511; 6,142,681; and 6,136,541 -- that cover the use of QRI for hybridized biochip and DNA microarray patterns, including diagnostic applications.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.